Joel Solomon Zev Schneider is COO at Solid Biosciences Inc. (SLDB). They have made 4 open-market trades across 1 company since 2018, most recently 2022-03-14.
CIK 0001727649
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLDB | 236,270 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2022-03-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLDB | SELL · 10b5-1 | 2022-03-14 | 2022-03-15 | $1.10 | $34K | +20.2% | +1.0% | -38.0% |
| SLDB | SELL | 2021-03-12 | 2021-03-15 | $8.84 | $207K | -28.2% | -34.7% | -49.4% |
| SLDB | SELL | 2021-01-28 | 2021-01-29 | $6.14 | $21K | +25.3% | +30.7% | -20.6% |
| SLDB | SELL | 2020-07-28 | 2020-07-29 | $2.42 | $10K | +10.7% | -2.9% | +38.9% |
| SLDB | SELL | 2018-11-15 | 2018-11-19 | $30.84 | $1.4M | -3.1% | -30.7% | -74.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.